ALTERITY THERAPEUTICS LIMITED SPON ADS EA REPR 60 ORD SHS ATHE 深 滬
等待開盤 10-04 09:30:00 美东时间
4.25
+0.060
+1.43%
華盛通- 最 高4.27
- 今 開4.22
- 成交量 1.03万股
- 最 低 4.0905
- 昨 收 4.19
- 總市值 6291.45万
- 52周最高 7.00
- 市盈率 靜 --
- 換手率 0.07%
- 52周最低 1.001
- 委 比 30.72%
- 總股本 1480.34万
- 歷史最高 51.50
- 量 比 0.48
- 振 幅 4.28%
- 歷史最低 1.001
- 每 手 1
- 風險率 0.45%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多13 Top Press Releases from September
Including 2026's best colleges, several big IPO and M&A announcements, Red Lobster's latest menu addition, and a football headline recap. NEW YORK, Oct. 3, 2025 /PRNewswire/ -- With thousand...
10-03 18:02
Alterity to Present Multiple System Atrophy Drug Trial Results at Major Parkinson's Conference in Hawaii
Alterity Therapeutics ((ASX: ATH, NASDAQ:ATHE) ("Alterity" or "the Company"), a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative diseases, today announced that data
10-02 19:37
Ather Energy Grants Stock Options Under ESOP 2025
Ather Energy Limited ( ($IN:ATHERENERG) ) just unveiled an update. Ather Energy...
09-24 02:03
Ather Energy Expands Equity Through ESOP Allotment
Ather Energy Limited ( ($IN:ATHERENERG) ) has shared an announcement. Ather Ene...
09-21 19:54
Garmin celebrates global innovators and collaborations at 2025 Garmin Health Summit
Annual event recognizes top digital health solutions and connects international thought leaders OLATHE, Kan., Sept. 19, 2025 /PRNewswire/ -- Garmin (NYSE: GRMN) today announced the recipient...
09-19 19:01
Garmin powers live data for Oakley Meta Vanguard AI glasses
Meta AI app from the Garmin Connect IQ Store sends athletes real-time training insights and visual status LED updates OLATHE, Kan., Sept. 17, 2025 /PRNewswire/ -- Garmin (NYSE: GRMN) has an...
09-18 09:45
Garmin announces historic research collaboration with King's College London
Strategic agreement leverages Garmin biometric data for digital health research OLATHE, Kan., Sept. 17, 2025 /PRNewswire/ -- Garmin (NYSE: GRMN) today announced a major collaboration with Ki...
09-17 23:01
Garmin adds AMOLED displays to its Instinct Crossover hybrid smartwatches
Blend function and style with illuminated analog watch hands for clear visibility – day and night OLATHE, Kan., Sept. 17, 2025 /PRNewswire/ -- Garmin (NYSE: GRMN) today announced Instinct® C...
09-17 18:59
Alterity Therapeutics Presents ATH434-201 Phase 2 Data at the American Neurological Association Annual Meeting
Alterity Therapeutics announced positive results from its Phase 2 clinical trial of ATH434 for Multiple System Atrophy (MSA). The study showed that ATH434, at 50 mg and 75 mg doses, slowed disease progression and was well tolerated. Key findings included reduced disease severity, improvement in core symptoms, and maintained function in daily activities. The drug also reduced iron accumulation in affected brain regions, indicating target engagemen...
09-15 11:25
Alterity Therapeutics’ ATH434 Shows Promise in Phase 2 MSA Trial
Alterity Therapeutics ( ($AU:ATH) ) just unveiled an update. Alterity Therapeut...
09-15 11:19
